looks like someone is moving themselves up the value chainthe guy who cuts down the tree does not make anywhere near the money as the guy who sells the tree as paper!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%